<DOC>
	<DOCNO>NCT01123057</DOCNO>
	<brief_summary>This hospital-based interventional prospective study . Patients clinical keratoconus LASIK keratectasia present Singapore National Eye Centre meet eligibility criterion recruit study . The aim study assess safety efficacy riboflavin-UVA induced cross-linking treatment corneal ectasia</brief_summary>
	<brief_title>Riboflavin-UVA Induced Collagen Crosslinking Treatment Corneal Ectasia</brief_title>
	<detailed_description>The purpose evaluation ass safety efficacy riboflavin-UVA induced cross-linking treatment corneal ectasia due keratoconus LASIK keratectasia . The principle procedure induce collagen crosslinking corneal stroma use riboflavin/UVA-treatment . The technique involve topical application riboflavin/dextran solution onto eye removal corneal epithelium . After initial riboflavin application 30 minute , UVA light shone onto cornea another 30 minute continue topical riboflavin application . A thorough examination perform evaluate follow pre-operatively : - Manifest refraction result - Uncorrected visual acuity ( UCVA ) best correct visual acuity ( BCVA ) - Cycloplegic refraction result - Uncorrected visual acuity ( UCVA ) best correct visual acuity ( BCVA ) - Slit-lamp biomicroscopy photography - Intraocular pressure measurement - Fundoscopy - Corneal topography use Orbscan II Pentacam - Corneal aberrometry measurement use Technolas Zywave Aberrometer - Endothelial cell count measurement use Konan noncontact endothelial cell analyser - Confocal microscopy - Corneal hysteresis measurement use Ocular Response Analyser - Subjective feedback quality vision ( VF 14 assessment ) Post-operative Assessment ( 1 day , 1 week , 1 month , 3 month , 6 month 1 year postoperatively ) - Uncorrected visual acuity best correct visual acuity manifest refraction - Cycloplegic refraction result - uncorrected visual acuity best correct visual acuity - Subjective visual outcome rating - Slit lamp examination photography - Fundoscopy - Corneal topography - Aberrometry measurement - Endothelial cell count - Confocal microscopy - Corneal hysteresis measurement - Report adverse event</detailed_description>
	<mesh_term>Dilatation , Pathologic</mesh_term>
	<mesh_term>Corneal Diseases</mesh_term>
	<mesh_term>Riboflavin</mesh_term>
	<criteria>Patients must clinical evidence keratoconus LASIK keratectasia ( moderate severe ) Visual acuity contact lenses must better equal 6/12 ( 20/40 ) . Patients must intolerant contact lens , i.e. , must unable wear contact lens whole day . Patients minimum corneal thickness 400um ( cornea swell state denude epithelium surgery ) . In term general health , patient must illnesses pose immediate threat life . Patients must 18 year age . Patients ' contact lens wear must stop 3 day prior preop assessment Patients wear lens day surgery Any vitamin C intake must stop 1 week prior surgery Both eye may recruit eligible . Patients noninflammatory corneal thin disorder pellucid marginal degeneration , keratoglobus posterior keratoconus may recruit corneal thickness &lt; 400 Âµm swollen state epithelial healing disorder ( e.g . mapdotfingerprint dystrophy , rheumatic disorder ) refractive keratotomy corneal melt condition herpes keratitis ( UV activate herpes virus ) associate systemic disorder Down 's syndrome Pregnancy Breastfeeding . Patients history herpetic keratitis . Patients autoimmune disease Patients IOP &gt; 21mmHg Patients cataracts Patients take part biomedical research 30 day prior start study . Patients alcohol abuse , psychological weakness , uncooperative disposition .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>keratoconus</keyword>
	<keyword>collagen cross-linking</keyword>
	<keyword>LASIK ectasia</keyword>
	<keyword>keratoconus , lasik ectasia</keyword>
</DOC>